pGX2303

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamepGX2303
Drug Alias NamepDNA vaccine (Inovio Pharmaceuticals)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionRespiratory syncytial virus F protein modulators
TargetsRespiratory syncytial virus F protein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A